6533b7dcfe1ef96bd1272bc0
RESEARCH PRODUCT
Production of CSSi013-A (9360) iPSC line from an asymptomatic subject carrying an heterozygous mutation in TDP-43 protein
Angela D'anziElisa PerciballiGiorgia RuotoloDaniela FerrariAntonietta NotaroIvan LombardiMaurizio GelatiKatia FrezzaLaura BernardiniIsabella TorrenteAlessandro De LucaVincenzo La BellaAngelo Luigi VescoviJessica Rosatisubject
DNA-Binding ProteinsHeterozygoteDNA-Binding ProteinAmyotrophic Lateral SclerosisInduced Pluripotent Stem CellsMutationHumansCell BiologyGeneral MedicineInduced Pluripotent Stem CellDevelopmental BiologyAmyotrophic Lateral SclerosiHumandescription
Amyotrophic Lateral Sclerosis (ALS) is a fatal disease affecting both upper and lower motoneurons. The transactive response DNA binding protein (TARDBP) gene, encoding for TDP-43, is one of the most commonly mutated gene associated with familial cases of ALS (10%). We generated a human induced pluripotent stem cell (hiPSC) line from the fibroblasts of an asymptomatic subject carrying the TARDBP p.G376D mutation. This mutation is very rare and was described in a large Apulian family, in which all ALS affected members are carriers of the mutation. The subject here described is the first identified asymptomatic carrier of the mutation.
year | journal | country | edition | language |
---|---|---|---|---|
2022-08-01 |